Dallas-based Aerus LLC, announces that it received Class II Medical Device clearance from the U.S. FDA for the Aerus Medical Guardian with ActivePure Technology, an active air purifier designed for healthcare environments. The Aerus Medical Guardian with ActivePure Technology, a free-standing, portable unit intended for use in professional healthcare environments, is a 24/7 airborne contaminant reduction solution. Specifically, it uses NASA-inspired ActivePure Technology to purify the air continuously and actively without the use of ozone.
Moreover, the Aerus Medical Guardian with ActivePure Technology works continuously to protect the rooms where it is installed, even when occupied by large numbers of people. The device is used to reduce staphylococcus epidermidis and erwinia herbicola bacteria; MS2 and Phi-X174 viruses; aspergillus niger fungal spores; and bacillus globigii bacterial spores from the air in a temperature-controlled professional healthcare-environment of 70°-71° Fahrenheit, 40%-45% RH.
“Until now, there has not been a clear gold standard in preventative measures for air purification in healthcare settings—and the Aerus Medical Guardian with ActivePure Technology fills that void,” says Joe Urso, CEO of Aerus. “We believe our breakthrough technology will be a gamechanger in hospitals.
“Never have hospitals and medical facilities had an active air-purification system that works as quickly to reduce airborne pathogens as does the Aerus Medical Guardian with ActivePure Technology,” Urso adds. “Our powerful technology and affordable Aerus Medical Guardian unit offers healthcare providers and their patients the higher level of protection they deserve.”
